Publications by authors named "Jim Paul"

Claim this Profile
Q
Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER-2 cohort study.
Sudha Sundar, Carole Cummins, Satyam Kumar, Joanna Long, Vivek Arora, Jim Paul

BJOG· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for a systematic review and thematic synthesis of patient experiences of central venous access devices in anti-cancer treatment.
Caoimhe Ryan, Hannah Hesselgreaves, Olivia Wu, Jim Paul, Judith Dixon-Hughes

Syst Rev· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational study.
Selina Tsim, Caroline Kelly, Laura Alexander, Carol McCormick, Fiona Thomson, Jim Paul

BMJ Open· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hickman catheter and implantable port devices for the delivery of chemotherapy: a phase II randomised controlled trial and economic evaluation.
Olivia Wu, Kathleen Boyd, Jim Paul, Elaine McCartney, Moira Ritchie

Br J Cancer· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer.
Kelly L Bolton, Jonathan Tyrer, Honglin Song, Susan J Ramus, Maria Notaridou, Jim Paul, Paul D P Pharoah

Nat Genet· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decision analytic cost-effectiveness model to compare prostate cryotherapy to androgen deprivation therapy for treatment of radiation recurrent prostate cancer.
Kathleen A Boyd, Rob J Jones, Jim Paul, Fiona Birrell, Andrew H Briggs

BMJ Open· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.
Sharon E Johnatty, Jonathan Beesley, Bo Gao, Xiaoqing Chen, Yi Lu, Jim Paul

Gynecol Oncol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cumulative genetic risk predicts platinum/taxane-induced neurotoxicity.
Sarah McWhinney-Glass, Stacey J Winham, Daniel L Hertz, Jane Yen Revollo, Jim Paul

Clin Cancer Res· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis.
Alex J Mitchell, David W Ferguson, John Gill, Jim Paul, Paul Symonds

Lancet Oncol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Raf kinase inhibitor protein expression combined with peritoneal involvement and lymphovascular invasion predicts prognosis in Dukes' B colorectal cancer patients.
Brendan Doyle, Suzanne Hagan, Fahd Al-Mulla, Lucy Scott, Sharon Harden, Jim Paul

Histopathology· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survey on the management of early cervical cancer among members of the GCIG.
Rhona Lindsay, Jim Paul, Nadeem Siddiqui, Jonathan Davis, David K Gaffney

Int J Gynecol Cancer· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients.
R Stephanie Huang, Sharon E Johnatty, Eric R Gamazon, Hae Kyung Im, Dana Ziliak, Jim Paul

Clin Cancer Res· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.
Paul D P Pharoah, Rachel T Palmieri, Susan J Ramus, Simon A Gayther, Irene L Andrulis, Paul Harnett, Jim Paul

Clin Cancer Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival.
Wei Dai, Jens M Teodoridis, Constanze Zeller, Janet Graham, Jenny Hersey, Jim Paul

Clin Cancer Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common variants at 19p13 are associated with susceptibility to ovarian cancer.
Kelly L Bolton, Jonathan Tyrer, Honglin Song, Susan J Ramus, Maria Notaridou, Jim Paul, Paul D P Pharoah

Nat Genet· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009.
Edward L Trimble, Michael J Birrer, William J Hoskins, Christian Marth, Ray Petryshyn, Jim Paul

Int J Gynecol Cancer· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series.
Roshan Agarwal, Charlie Gourley, Timothy J Perren, Nicholas Reed, David E Parkin, Jim Paul

Eur J Cancer· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased incidence of visceral metastases in scottish patients with BRCA1/2-defective ovarian cancer: an extension of the ovarian BRCAness phenotype.
Charlie Gourley, Caroline O Michie, Patricia Roxburgh, Timothy A Yap, Sharon Harden, Jim Paul, Paul Mitchell

J Clin Oncol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WWOX tumour suppressor gene polymorphisms and ovarian cancer pathology and prognosis.
Adam J W Paige, Manuela Zucknick, Szymon Janczar, Jim Paul, Charles A Mein

Eur J Cancer· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.
Sharon E Johnatty, Jonathan Beesley, Jim Paul, Sian Fereday, Amanda B Spurdle, Paul R Harnett

Clin Cancer Res· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylation Linear Discriminant Analysis (MLDA) for identifying differentially methylated CpG islands.
Wei Dai, Jens M Teodoridis, Janet Graham, Constanze Zeller, Tim H M Huang, Jim Paul

BMC Bioinformatics· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An exploration into study design for biomarker identification: issues and recommendations.
Jacqueline A Hall, Robert Brown, Jim Paul

Cancer Genomics Proteomics· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer.
Sharon Marsh, Jim Paul, Cristi R King, Gillian Gifford, Howard L McLeod

J Clin Oncol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma.
Noelle O'Rourke, Jose Curto Garcia, Jim Paul, Claire Lawless, Rhona McMenemin

Radiother Oncol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCB1 2677G>T/A genotype and paclitaxel pharmacogenetics in ovarian cancer.
Sharon Marsh, Cristi R King, Howard L McLeod, Jim Paul, Gillian Gifford

Clin Cancer Res· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis